{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T03:13:07Z","timestamp":1785381187092,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:00:00Z","timestamp":1781136000000},"content-version":"vor","delay-in-days":54,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Program","doi-asserted-by":"crossref","award":["230111"],"award-info":[{"award-number":["230111"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Program","doi-asserted-by":"crossref","award":["230111"],"award-info":[{"award-number":["230111"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Program","doi-asserted-by":"crossref","award":["230111"],"award-info":[{"award-number":["230111"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018556","name":"Suzhou Science and Technology Program","doi-asserted-by":"crossref","award":["230111"],"award-info":[{"award-number":["230111"]}],"id":[{"id":"10.13039\/501100018556","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-46904-0","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T10:15:38Z","timestamp":1776507338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The curcumin derivative DMC-GF promotes ferroptosis through the Nrf2\/HMOX1 pathway, increasing glioma susceptibility to temozolomide"],"prefix":"10.1038","volume":"16","author":[{"given":"Huiling","family":"Tao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuetao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"46904_CR1","doi-asserted-by":"publisher","first-page":"105780","DOI":"10.1016\/j.phrs.2021.105780","volume":"171","author":"W Wu","year":"2021","unstructured":"Wu, W. et al. Glioblastoma multiforme (GBM): An overview of current therapies and mechanisms of resistance. Pharmacol. Res. 171, 105780. https:\/\/doi.org\/10.1016\/j.phrs.2021.105780 (2021).","journal-title":"Pharmacol. Res."},{"key":"46904_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12010164","author":"CM von Bebber","year":"2020","unstructured":"Bebber, C. M., M\u00fcller, F., Clemente, P., Weber, L. & von Karstedt, S. J. Ferroptosis Cancer Cell. Biol. Cancers (Basel) (2020). https:\/\/doi.org\/10.3390\/cancers12010164","journal-title":"Ferroptosis Cancer Cell. Biology Cancers (Basel)"},{"key":"46904_CR3","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1200\/jop.2017.025536","volume":"13","author":"JY Nam","year":"2017","unstructured":"Nam, J. Y. & de Groot, J. F. Treatment of Glioblastoma. J. Oncol. Pract. 13, 629\u2013638. https:\/\/doi.org\/10.1200\/jop.2017.025536 (2017).","journal-title":"J. Oncol. Pract."},{"key":"46904_CR4","doi-asserted-by":"publisher","first-page":"299","DOI":"10.3322\/caac.21613","volume":"70","author":"AC Tan","year":"2020","unstructured":"Tan, A. C. et al. Management of glioblastoma: State of the art and future directions. CA Cancer J. Clin. 70, 299\u2013312. https:\/\/doi.org\/10.3322\/caac.21613 (2020).","journal-title":"CA Cancer J. Clin."},{"key":"46904_CR5","doi-asserted-by":"publisher","first-page":"1476436","DOI":"10.3389\/fimmu.2024.1476436","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu, J., Peng, J., Jiang, J. & Liu, Y. Clinical immunotherapy in glioma: current concepts, challenges, and future perspectives. Front. Immunol. 15, 1476436. https:\/\/doi.org\/10.3389\/fimmu.2024.1476436 (2024).","journal-title":"Front. Immunol."},{"key":"46904_CR6","doi-asserted-by":"publisher","first-page":"e1695","DOI":"10.1002\/wnan.1695","volume":"13","author":"X Zhou","year":"2021","unstructured":"Zhou, X., Smith, Q. R. & Liu, X. Brain penetrating peptides and peptide-drug conjugates to overcome the blood-brain barrier and target CNS diseases. Wiley Interdiscip Rev. Nanomed. Nanobiotechnol. 13, e1695. https:\/\/doi.org\/10.1002\/wnan.1695 (2021).","journal-title":"Wiley Interdiscip Rev. Nanomed. Nanobiotechnol."},{"key":"46904_CR7","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/annonc\/mdx106","volume":"28","author":"M Touat","year":"2017","unstructured":"Touat, M., Idbaih, A., Sanson, M. & Ligon, K. L. Glioblastoma targeted therapy: updated approaches from recent biological insights. Ann. Oncol. 28, 1457\u20131472. https:\/\/doi.org\/10.1093\/annonc\/mdx106 (2017).","journal-title":"Ann. Oncol."},{"key":"46904_CR8","doi-asserted-by":"publisher","first-page":"917537","DOI":"10.3389\/fonc.2022.917537","volume":"12","author":"M Lu","year":"2022","unstructured":"Lu, M. et al. The molecular mechanisms of ferroptosis and its role in glioma progression and treatment. Front. Oncol. 12, 917537. https:\/\/doi.org\/10.3389\/fonc.2022.917537 (2022).","journal-title":"Front. Oncol."},{"key":"46904_CR9","doi-asserted-by":"publisher","first-page":"1346585","DOI":"10.3389\/fimmu.2024.1346585","volume":"15","author":"H Wang","year":"2024","unstructured":"Wang, H. et al. Deciphering the link: ferroptosis and its role in glioma. Front. Immunol. 15, 1346585. https:\/\/doi.org\/10.3389\/fimmu.2024.1346585 (2024).","journal-title":"Front. Immunol."},{"key":"46904_CR10","doi-asserted-by":"publisher","first-page":"833642","DOI":"10.3389\/fcvm.2022.833642","volume":"9","author":"D Wu","year":"2022","unstructured":"Wu, D. et al. Identification of HMOX1 as a Critical Ferroptosis-Related Gene in Atherosclerosis. Front. Cardiovasc. Med. 9, 833642. https:\/\/doi.org\/10.3389\/fcvm.2022.833642 (2022).","journal-title":"Front. Cardiovasc. Med."},{"key":"46904_CR11","doi-asserted-by":"publisher","first-page":"119935","DOI":"10.1016\/j.lfs.2021.119935","volume":"284","author":"Z Meng","year":"2021","unstructured":"Meng, Z. et al. HMOX1 upregulation promotes ferroptosis in diabetic atherosclerosis. Life Sci. 284, 119935. https:\/\/doi.org\/10.1016\/j.lfs.2021.119935 (2021).","journal-title":"Life Sci."},{"key":"46904_CR12","doi-asserted-by":"publisher","first-page":"13291","DOI":"10.1074\/jbc.R900010200","volume":"284","author":"T Nguyen","year":"2009","unstructured":"Nguyen, T., Nioi, P. & Pickett, C. B. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J. Biol. Chem. 284, 13291\u201313295. https:\/\/doi.org\/10.1074\/jbc.R900010200 (2009).","journal-title":"J. Biol. Chem."},{"key":"46904_CR13","doi-asserted-by":"publisher","unstructured":"Yan, R. et al. NRF2, a Superstar of Ferroptosis. Antioxidants (Basel) 12. (2023). https:\/\/doi.org\/10.3390\/antiox12091739","DOI":"10.3390\/antiox12091739"},{"key":"46904_CR14","doi-asserted-by":"publisher","first-page":"102371","DOI":"10.1016\/j.xcrm.2025.102371","volume":"6","author":"Q Zhou","year":"2025","unstructured":"Zhou, Q. et al. Vorapaxar enhanced mitochondria-associated ferroptosis primes cancer immunotherapy via targeting FOXO1\/HMOX1 axis. Cell. Rep. Med. 6, 102371. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102371 (2025).","journal-title":"Cell. Rep. Med."},{"key":"46904_CR15","doi-asserted-by":"publisher","first-page":"113729","DOI":"10.1016\/j.biopha.2022.113729","volume":"155","author":"L Gaiaschi","year":"2022","unstructured":"Gaiaschi, L. et al. The power of a novel combined anticancer therapy: challenge and opportunity of micotherapy in the treatment of Glioblastoma Multiforme. Biomed. Pharmacother. 155, 113729. https:\/\/doi.org\/10.1016\/j.biopha.2022.113729 (2022).","journal-title":"Biomed. Pharmacother"},{"key":"46904_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1615\/CritRevEukaryotGeneExpr.2025058526","volume":"35","author":"X Guo","year":"2025","unstructured":"Guo, X., Han, T. & Zhang, L. Mechanism of Curcumin Inhibition of Malignant Progression of Lung Cancer Cells by Regulating Ferroptosis via the NRF2\/HMOX1 Pathway. Crit. Rev. Eukaryot. Gene Expr. 35, 39\u201351. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2025058526 (2025).","journal-title":"Crit. Rev. Eukaryot. Gene Expr"},{"key":"46904_CR17","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1186\/s12967-025-06355-z","volume":"23","author":"L Shi","year":"2025","unstructured":"Shi, L. et al. DMC-BH derivative DMC-GF inhibits the growth of glioma stem cells by targeting the TRIM33\/SLC25A1\/mitochondrial oxidative phosphorylation pathway. J. Transl Med. 23, 363. https:\/\/doi.org\/10.1186\/s12967-025-06355-z (2025).","journal-title":"J. Transl Med."},{"key":"46904_CR18","doi-asserted-by":"publisher","first-page":"23795","DOI":"10.18632\/aging.103981","volume":"12","author":"L Shi","year":"2020","unstructured":"Shi, L., Sun, G. & Zhang, Y. Demethoxycurcumin analogue DMC-BH exhibits potent anticancer effects on orthotopic glioblastomas. Aging (Albany NY). 12, 23795\u201323807. https:\/\/doi.org\/10.18632\/aging.103981 (2020).","journal-title":"Aging (Albany NY)"},{"key":"46904_CR19","doi-asserted-by":"publisher","first-page":"e2203958","DOI":"10.1002\/adma.202203958","volume":"34","author":"Y Zou","year":"2022","unstructured":"Zou, Y. et al. Brain Co-Delivery of Temozolomide and Cisplatin for Combinatorial Glioblastoma Chemotherapy. Adv. Mater. 34, e2203958. https:\/\/doi.org\/10.1002\/adma.202203958 (2022).","journal-title":"Adv. Mater."},{"key":"46904_CR20","doi-asserted-by":"publisher","unstructured":"Szklener, K. et al. New Directions in the Therapy of Glioblastoma. Cancers (Basel) 14, (2022). https:\/\/doi.org\/10.3390\/cancers14215377","DOI":"10.3390\/cancers14215377"},{"key":"46904_CR21","doi-asserted-by":"publisher","first-page":"963096","DOI":"10.3389\/fonc.2022.963096","volume":"12","author":"T Dong","year":"2022","unstructured":"Dong, T. et al. Hepcidin is upregulated and is a potential therapeutic target associated with immunity in glioma. Front. Oncol. 12, 963096. https:\/\/doi.org\/10.3389\/fonc.2022.963096 (2022).","journal-title":"Front. Oncol."},{"key":"46904_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.jconrel.2024.11.048","volume":"377","author":"L Zhu","year":"2025","unstructured":"Zhu, L. et al. Self-catalyzed nitric oxide nanocomplexes induce ferroptosis for cancer immunotherapy. J. Control Release. 377, 524\u2013539. https:\/\/doi.org\/10.1016\/j.jconrel.2024.11.048 (2025).","journal-title":"J. Control Release"},{"key":"46904_CR23","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.jnutbio.2011.05.006","volume":"23","author":"X Zou","year":"2012","unstructured":"Zou, X. et al. Stimulation of GSH synthesis to prevent oxidative stress-induced apoptosis by hydroxytyrosol in human retinal pigment epithelial cells: activation of Nrf2 and JNK-p62\/SQSTM1 pathways. J. Nutr. Biochem. 23, 994\u20131006. https:\/\/doi.org\/10.1016\/j.jnutbio.2011.05.006 (2012).","journal-title":"J. Nutr. Biochem."},{"key":"46904_CR24","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.7150\/ijbs.59404","volume":"17","author":"R Wei","year":"2021","unstructured":"Wei, R. et al. Tagitinin C induces ferroptosis through PERK-Nrf2-HO-1 signaling pathway in colorectal cancer cells. Int. J. Biol. Sci. 17, 2703\u20132717. https:\/\/doi.org\/10.7150\/ijbs.59404 (2021).","journal-title":"Int. J. Biol. Sci."},{"key":"46904_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2022.06.010","volume":"188","author":"C Yang","year":"2022","unstructured":"Yang, C. et al. Flavonoid 4,4\u2019-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1\/Nrf2\/HMOX1 pathway and inhibiting FECH. Free Radic Biol. Med. 188, 14\u201323. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2022.06.010 (2022).","journal-title":"Free Radic Biol. Med."},{"key":"46904_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev-pharmtox-011112-140320","volume":"53","author":"Q Ma","year":"2013","unstructured":"Ma, Q. Role of nrf2 in oxidative stress and toxicity. Annu. Rev. Pharmacol. Toxicol. 53, 401\u2013426. https:\/\/doi.org\/10.1146\/annurev-pharmtox-011112-140320 (2013).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"46904_CR27","doi-asserted-by":"publisher","first-page":"111202","DOI":"10.1016\/j.biopha.2020.111202","volume":"136","author":"H Lin","year":"2021","unstructured":"Lin, H. et al. EF24 induces ferroptosis in osteosarcoma cells through HMOX1. Biomed. Pharmacother. 136, 111202. https:\/\/doi.org\/10.1016\/j.biopha.2020.111202 (2021).","journal-title":"Biomed. Pharmacother"},{"key":"46904_CR28","doi-asserted-by":"publisher","first-page":"e2100997","DOI":"10.1002\/advs.202100997","volume":"8","author":"X Yao","year":"2021","unstructured":"Yao, X. et al. Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells. Adv. Sci. (Weinh). 8, e2100997. https:\/\/doi.org\/10.1002\/advs.202100997 (2021).","journal-title":"Adv. Sci. (Weinh)"},{"key":"46904_CR29","doi-asserted-by":"publisher","first-page":"1071946","DOI":"10.3389\/fphar.2022.1071946","volume":"13","author":"T Ren","year":"2022","unstructured":"Ren, T. et al. Zoledronic acid induces ferroptosis by reducing ubiquinone and promoting HMOX1 expression in osteosarcoma cells. Front. Pharmacol. 13, 1071946. https:\/\/doi.org\/10.3389\/fphar.2022.1071946 (2022).","journal-title":"Front. Pharmacol."},{"key":"46904_CR30","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.21037\/atm-22-5750","volume":"10","author":"R Zhu","year":"2022","unstructured":"Zhu, R. et al. Ferroptosis-related genes with post-transcriptional regulation mechanisms in hepatocellular carcinoma determined by bioinformatics and experimental validation. Ann. Transl Med. 10, 1390. https:\/\/doi.org\/10.21037\/atm-22-5750 (2022).","journal-title":"Ann. Transl Med."},{"key":"46904_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/vetsci11100464","author":"Z Zhu","year":"2024","unstructured":"Zhu, Z. et al. Advances in the Effects of Heat Stress on Ovarian Granulosa Cells: Unveiling Novel Ferroptosis Pathways. Vet. Sci. (2024). https:\/\/doi.org\/10.3390\/vetsci11100464","journal-title":"Vet. Sci."},{"key":"46904_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1167\/iovs.63.10.3","volume":"63","author":"X Zuo","year":"2022","unstructured":"Zuo, X. et al. AKR1C1 Protects Corneal Epithelial Cells Against Oxidative Stress-Mediated Ferroptosis in Dry Eye. Invest. Ophthalmol. Vis. Sci. 63, 3. https:\/\/doi.org\/10.1167\/iovs.63.10.3 (2022).","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46904-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46904-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:03:46Z","timestamp":1781175826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-46904-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["46904"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-46904-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"27 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Institutional Animal Care and Use Committee of Wuhan Myhalic Biotechnology Co., Ltd. approved all animal procedures. Confirming that all experiments were performed in accordance with relevant guidelines and regulations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"18069"}}